*MESOBLAST TO MEET WITH FDA NEXT MONTH TO DISCUSS REXLEMESTROCEL-L AND OPIOID CESSATION
*Further company coverage: MSB.AX
* ((Reuters.Briefs@thomsonreuters.com;))
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 05-NOV-202501:34:57 GMT